Search Within

David H Abramson

  1. "Early Drug Development Service"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (6)
  2. Early Drug Development Service (6)
  3. Pediatrics, Department of (6)
  4. Solid Tumor Oncology Division (6)
  5. Surgery (6)
  6. Genitourinary Oncology Service (5)

More Groups

People
  1. Eli Diamond (5)
  2. Alexander Drilon (4)
  3. David Hyman (4)
  4. Alessandro Pastore (3)
  5. Benjamin Durham (3)
  6. David Solit (3)

More People

Years
  1. 2021 (2)
  2. 2020 (2)
  3. 2019 (1)
  4. 2018 (1)
Publications
  1. Blood (1)
  2. JAMA Ophthalmology (1)
  3. Nature Medicine (1)
  4. Ocular Oncology and Pathology (1)
  5. Ophthalmology Retina (1)
  6. Pediatric Blood and Cancer (1)
Publishers
  1. American Medical Association (1)
  2. American Society of Hematology (1)
  3. Elsevier Inc. (1)
  4. Karger (1)
  5. Nature Publishing Group (1)
  6. Wiley Periodicals, Inc (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and morphologic characteristics of extracellular signal-regulated kinase inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Canestraro, J.; Haggag-Lindgren, D.; Harding, J. J.; Diamond, E. L.; Drilon, A.; Li, B. T.; Iyer, G.; Schram, A. M.; Abramson, D. H.
    Ophthalmology Retina (2021)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of fibroblast growth factor receptor inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Harding, J. J.; Schram, A. M.; Canestraro, J.; Haggag-Lindgren, D.; Heinemann, M.; Kriplani, A.; Jhaveri, K.; Voss, M. H.; Bajorin, D.; more...
    JAMA Ophthalmology (2021)

    Fulltext@MSK | Save
  • MEK inhibitor-associated central retinal vein occlusion associated with hyperhomocysteinemia and MTHFR variants
    Journal Article

    Francis, J. H.; Diamond, E. L.; Chi, P.; Jaben, K.; Hyman, D. M.; Abramson, D. H.
    Ocular Oncology and Pathology (2020)

    Fulltext@MSK | Save
  • Novel alterations in CSF1R, RET, and other diverse kinases in the histiocytoses with biochemical and structural insights into their mechanisms of activation
    Meeting Abstract

    Durham, B.; Lopez-Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S.; Pastore, A.; Mandelker, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Lopez Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S. X.; Pastore, A.; Yoshimi, A.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
    Blood (2018)

    Fulltext@MSK | Save